Market Place
Sourcing Support
Shorla Oncology Announces FDA Approval of JYLAMVO™ for Pediatrics
29 Oct 2024 //
BUSINESSWIRE
Alembic`s Generic Clindamycin Phosphate Receives Approval the U.S.
03 Jun 2024 //
FDA
Metoject subcutaneous inj pen launches in Japan rheumatic arthritis treatment
22 May 2024 //
BIOSPECTRUM ASIA
Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate
20 May 2024 //
ACCESSWIRE
Elite Labs`s Generic Methotrexate Sodium Receives Approval in U.S
16 May 2024 //
FDA
Shorla & EVERSANA Announce U.S. Commercial Launch of FDA-Approved JYLAMVO
19 Dec 2023 //
PR NEWSWIRE
Sandoz opens two new facilities; Gates Foundation funds needle-free vaccines
16 Nov 2023 //
ENDPTS
Enforcement Report - Week of November 1, 2023
01 Nov 2023 //
FDA
Daito`s Generic Methotrexate Sodium Receives Approval in the U.S.
07 Aug 2023 //
FDA
NCCN Issues Guideline Update on the Use of High-Dose Methotrexate, Glucarpidase
07 Jul 2023 //
ONCLIVE
Long-Term Data From the MIRROR Randomized Controlled Trial of KRYSTEXXA
06 Jul 2023 //
BUSINESSWIRE
Aldeyra Announces Improvement from Baseline in Retinal in Ph2 Trial of ADX?2191
29 Jun 2023 //
BUSINESSWIRE
Aldeyra Therapeutics Provides Regulatory Update on ADX-2191
21 Jun 2023 //
BUSINESSWIRE
US seeks new suppliers of highly used cancer drug methotrexate in short supply
09 Jun 2023 //
REUTERS
Intas Pharmaceuticals Limited on FDA Import Alert List
06 Jun 2023 //
FDA
Life-threatening bacteria found in Hyderabad company`s cancer drug: WHO
28 Mar 2023 //
TIMES OF INDIA
FDA Accepts for Priority Review ADX-2191 New Drug Application
02 Mar 2023 //
BUSINESSWIRE
Methotrexate use is linked to an increased risk of skin cancer
08 Feb 2023 //
HEALTH ET
REGiMMUNE touts `compelling` data in stem call transplants
20 Dec 2022 //
FIERCEBIOTECH
Sustained Patient Response to KRYSTEXXA® (pegloticase) Inj with Methotrexate
08 Nov 2022 //
BUSINESSWIRE
Data Support the Use of KRYSTEXXA with Methotrexate to Treat Uncontrolled Gout
05 Nov 2022 //
BUSINESSWIRE
Aldeyra Schedules Conference to Announce Results from PIII Trial of ADX-2191
05 Oct 2022 //
BUSINESSWIRE
Japan approves subcutaneous injection formulation for rheumatoid arthritis
28 Sep 2022 //
BIOSPECTRUMASIA
Horizon Therapeutics plc Reports 2nd Quarter 2022 Financial Results
03 Aug 2022 //
BUSINESSWIRE
Krystexxa plus methotrexate approved for uncontrolled gout
09 Jul 2022 //
FIERCEPHARMA
KRYSTEXXA Plus Methotrexate Resulted in Improvement in Efficacy and Safety
01 Jun 2022 //
BUSINESSWIRE
Assertio Holdings Partners with BlinkRx to Support Use of Otrexup
31 Mar 2022 //
GLOBENEWSWIRE
Aldeyra Tx Initiates Phase 2 Clinical Trial of ADX-2191 for Retinitis Pigmentosa
08 Mar 2022 //
BUSINESSWIRE
FDA Grants Priority Review to Horizon Tx of sBLA for KRYSTEXXA Plus Methotrexate
07 Mar 2022 //
BUSINESSWIRE
Enforcement Report - Week of February 2, 2022
02 Feb 2022 //
FDA
Horizon Submits Supplemental Biologics License for KRYSTEXXA + Methotrexate
10 Jan 2022 //
BUSINESSWIRE
Aldeyra Completes Enrollment in Part 1 of Phase 3 GUARD Trial of ADX-2191
04 Jan 2022 //
BUSINESSWIRE
AbbVie Expands Immunology Portfolio in EU with EC Approval of SKYRIZI
17 Nov 2021 //
PRNEWSWIRE
NICE approves treatment for rheumatoid arthritis
12 Oct 2021 //
PHARMAFILE
NICE recommends several treatment options to help thousands with moderate RA
10 Jun 2021 //
NICE
Treating Juvenile Idiopathic Arthritis to Target Associated With Reduced Pain
10 Jun 2021 //
FIRSTWORLDPHARMA
Equillium to Collaborate with Oxford & Kennedy Institute of Rheumatology
07 Jun 2021 //
GLOBENEWSWIRE
Enforcement Report - Week of January 20, 2021
20 Jan 2021 //
FDA
Azurity garners OPDP untitled letter for problematic emails
04 Dec 2020 //
RAPS
Initial study results show feasibility of outpatient methotrexate administration
12 Nov 2020 //
PRNEWSWIRE
The Association of Methotrexate, Sulfasalazine and Hydroxychloroquine Use
09 Nov 2020 //
ACRABSTRACTS
Horizon Initiates Clinical Trial to Assess Shorter Infusion for KRYSTEXXA®
30 Oct 2020 //
BUSINESSWIRE
Methotrexate once-weekly for autoimmune diseases
23 Sep 2020 //
GOV.UK
MIRROR Trial Showed positive results for Using KRYSTEXXA +Methotrexate
16 Sep 2020 //
BUSINESSWIRE
Health Canada Approves TREMFYA®* (guselkumab injection)
10 Sep 2020 //
NEWSWIRE
Accord Hlthcare’s Methotrexate Receives Approval In US
27 Aug 2020 //
FDA
Accord Healthcare`s Methotrexate Receives Approval In US
27 Aug 2020 //
FDA
Hikma launches Methotrexate Injection, USP and Methotrexate for Injection, USP
24 Jul 2020 //
PRESS RELEASE
Target Enrollment Reached in MIRROR Randomized Controlled Trial KRYSTEXXA®
22 Jul 2020 //
BIOSPACE
Fresenius Kabi enters marketing agreement for biosimilar product
28 May 2020 //
FRESENIUS-KABI
Study Underway to Examine the Planned Use of Voraxaze®
23 Apr 2020 //
PR NEWSWIR
Can-Fite Completes 50% Patient Enrollment in PhIII Rheumatoid Arthritis Study
03 Feb 2020 //
BUSINESSINSIDER
Eugia Pharma`s Generic Methotrexate Sodium Receives Approval in US
01 Feb 2020 //
FDA
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex™ Product Line
02 Dec 2019 //
PR NEWSWIRE
NIH funded study shows methotrexate is more effective than mycophenolate mofetil
13 Sep 2019 //
PHARMABIZ
EMA Warns of Dosing Errors With Methotrexate Drugs
16 Jul 2019 //
RAPS
AbbVie`s rising immunology star Skyrizi scores nod from England`s cost watchdog
16 Jul 2019 //
FIERCE PHARMA
Newly-Branded Azurity Wins FDA Approval for Liquid Form of Amlodipine
10 Jul 2019 //
BIOSPACE
Gilead Plans NDA for Rheumatoid Arthritis Drug Filgotinib
03 Jul 2019 //
BIOSPACE
